PepsiCo Adds Johnson & Johnson CEO to Board Amid Portfolio Evolution
Event summary
- PepsiCo elected Joaquin Duato, CEO of Johnson & Johnson, to its Board of Directors effective December 1, 2026.
- Duato will serve on the Audit Committee, bringing 30+ years of experience in global healthcare leadership.
- PepsiCo generated $94B in net revenue in 2025, with a portfolio including 10+ billion-dollar brands.
- Duato's expertise in portfolio optimization and innovation aligns with PepsiCo's pep+ strategic transformation.
The big picture
PepsiCo's addition of a seasoned healthcare executive to its board underscores its focus on strategic portfolio shifts amid evolving consumer preferences. As the company pushes its pep+ transformation, Duato's experience in regulated markets and innovation could prove valuable in navigating sustainability challenges and growth opportunities. This move comes as consumer goods giants increasingly seek cross-industry governance perspectives to drive long-term resilience.
What we're watching
- Portfolio Strategy
- How Duato's healthcare expertise will influence PepsiCo's food and beverage portfolio evolution.
- Governance Dynamics
- Whether this appointment signals PepsiCo's push for more cross-industry board diversity.
- Execution Risk
- The pace at which PepsiCo can integrate Duato's insights into its pep+ sustainability framework.
Related topics